Literature DB >> 11277549

Osteoporosis: part II. Nonpharmacologic and pharmacologic treatment.

J E South-Paul1.   

Abstract

Family physicians will frequently encounter patients with osteoporosis, a condition that is often asymptomatic until a fracture occurs. Treatment of the fracture can be initiated without further diagnostic testing. Thereafter, treatment of osteoporosis includes (1) prevention of further bone loss through weight-bearing exercise, tobacco and alcohol avoidance, hormone replacement therapy in women, and raloxifene and calcium supplementation; (2) treatment of fracture-related pain with analgesics and calcitonin; (3) building bone mass when feasible with alendronate; and (4) modifying behaviors that increase the risk of falls. Patients without fracture who are at risk for osteoporosis can also benefit from these preventive measures. Furthermore, women of all ages should be encouraged to maintain a daily calcium intake of 1,000 to 1,500 mg and to participate in weight-bearing exercise for 30 minutes three times weekly to reduce their risk of falls and fractures. Persons at risk should avoid medications known to compromise bone density, such as glucocorticoids, thyroid hormones and chronic heparin therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11277549

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  5 in total

1.  The Relationship of Perceived Risk and Biases in Perceived Risk to Fracture Prevention Behavior in Older Women.

Authors:  Salene M W Jones; Nancy M Gell; Joshua A Roth; Delia Scholes; Andrea Z LaCroix
Journal:  Ann Behav Med       Date:  2015-10

2.  Incidence and causes for failure of treatment of women with proven osteoporosis.

Authors:  Noah Zafran; Zvi Liss; Ronit Peled; Michael Sherf; Haim Reuveni
Journal:  Osteoporos Int       Date:  2005-04-02       Impact factor: 4.507

3.  Comparative Study of the Effect of Resistance Exercises versus Aerobic Exercises in Postmenopausal Women Suffering from Insomnia.

Authors:  Gayatri Karandikar-Agashe; Ronika Agrawal
Journal:  J Midlife Health       Date:  2020-05-04

4.  Chronic Osteoporotic Pain in Mice: Cutaneous and Deep Musculoskeletal Pain Are Partially Independent of Bone Resorption and Differentially Sensitive to Pharmacological Interventions.

Authors:  Miyako Suzuki; Magali Millecamps; Lina Naso; Seiji Ohtori; Chisato Mori; Laura S Stone
Journal:  J Osteoporos       Date:  2017-02-19

Review 5.  Mechanisms of the analgesic effect of calcitonin on chronic pain by alteration of receptor or channel expression.

Authors:  Akitoshi Ito; Megumu Yoshimura
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.